OTCMKTS:TRUMY Terumo (TRUMY) Stock Price, News & Analysis $15.82 -0.38 (-2.35%) As of 11/20/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsShort Interest About Terumo Stock (OTCMKTS:TRUMY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Terumo alerts:Sign Up Key Stats Today's Range$15.81▼$16.0550-Day Range$13.25▼$16.4352-Week Range$12.08▼$16.81Volume104,249 shsAverage Volume173,504 shsMarket Capitalization$23.34 billionP/E Ratio32.96Dividend Yield0.38%Price TargetN/AConsensus RatingStrong Buy Company Overview Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies. Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.AI Generated. May Contain Errors. Read More Terumo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreTRUMY MarketRank™: 0.618040089085 of 5 starsTerumo scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.2 / 5Analyst RatingStrong Buy Amount of Analyst CoverageTerumo has only been the subject of 1 research reports in the past 90 days.Read more about Terumo's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-6.98% Earnings GrowthEarnings for Terumo are expected to decrease by -6.98% in the coming year, from $0.86 to $0.80 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Terumo is 31.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.72.Price to Earnings Ratio vs. SectorThe P/E ratio of Terumo is 31.92, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.45.Price to Book Value per Share RatioTerumo has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Terumo has been sold short.Short Interest Ratio / Days to CoverTerumo has a short interest ratio ("days to cover") of 0.13, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Terumo has recently increased by 150.52%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldTerumo has a dividend yield of 0.36%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthTerumo does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Terumo is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Terumo will have a dividend payout ratio of 7.50% next year. This indicates that Terumo will be able to sustain or increase its dividend.Read more about Terumo's dividend. News and Social Media1.9 / 5News Sentiment0.07 News SentimentTerumo has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Terumo this week, compared to 0 articles on an average week. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Terumo insiders have not sold or bought any company stock.Percentage Held by InstitutionsTerumo has minimal institutional ownership at this time.Read more about Terumo's insider trading history. Receive TRUMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRUMY Stock News HeadlinesTerumo (OTCMKTS:TRUMY) Shares Cross Above 50-Day Moving Average After Earnings MissNovember 15, 2026 | americanbankingnews.comTerumo (OTCMKTS:TRUMY) Shares Gap Down Following Weak EarningsNovember 15, 2026 | americanbankingnews.comCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.November 21 at 1:00 AM | Decentralized Masters (Ad)Terumo (OTCMKTS:TRUMY) Stock Falls 7.4% Following Weak EarningsNovember 14, 2026 | americanbankingnews.comTerumo Corporation (TRUMY) Q2 2027 Earnings Call TranscriptNovember 12, 2026 | seekingalpha.comTerumo ADR (TRUMY) RatiosOctober 24, 2026 | uk.investing.comTerumo ADR (TRUMY)September 5, 2026 | es.investing.comTerumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks TranscriptAugust 12, 2026 | seekingalpha.comSee More Headlines TRUMY Stock Analysis - Frequently Asked Questions How have TRUMY shares performed this year? Terumo's stock was trading at $14.49 at the beginning of the year. Since then, TRUMY shares have increased by 9.2% and is now trading at $15.82. How were Terumo's earnings last quarter? Terumo Corp. (OTCMKTS:TRUMY) posted its quarterly earnings data on Thursday, November, 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.06. The firm earned $1.96 billion during the quarter, compared to analysts' expectations of $1.94 billion. Terumo had a net margin of 9.31% and a trailing twelve-month return on equity of 7.03%. When did Terumo's stock split? Terumo shares split before market open on Thursday, March 28th 2024.The 2-1 split was announced on Thursday, March 28th 2024. The newly issued shares were distributed to shareholders after the market closes on Thursday, March 28th 2024. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. How do I buy shares of Terumo? Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/12/2026Today11/21/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:TRUMY Previous SymbolNASDAQ:TRUMY CIK1446672 Webwww.terumo.com Phone(133) 374-8111Fax813-3374-8399Employees30,000Year Founded1964Profitability EPS (Trailing Twelve Months)$0.48 Trailing P/E Ratio32.96 Forward P/E Ratio19.78 P/E GrowthN/ANet Income$897.03 million Net Margins9.31% Pretax Margin15.75% Return on Equity7.03% Return on Assets4.83% Debt Debt-to-Equity Ratio0.13 Current Ratio2.19 Quick Ratio1.37 Sales & Book Value Annual Sales$7.52 billion Price / Sales3.10 Cash Flow$1.07 per share Price / Cash Flow14.75 Book Value$7.09 per share Price / Book2.23Miscellaneous Outstanding Shares1,475,070,000Free FloatN/AMarket Cap$23.34 billion OptionableNot Optionable Beta0.82 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:TRUMY) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersSeven bucks, yours for life: my Black Friday indicator dealBase Camp Trading's Thomas Wood is giving away his proprietary Snapback Indicator for just $7 this Black Frida...Base Camp Trading | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredAre Tesla and SpaceX Going Bankrupt?Tesla and SpaceX shares crashed right after Democrats took the House and the Senate in the midterm election. E...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terumo Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terumo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.